The biotherapeutic Clostridium butyricum MIYAIRI 588 strain potentiates enterotropism of Rorγt+Treg and PD-1 blockade efficacy
ABSTRACTImmune checkpoint inhibitors (ICI) have been positioned as a standard of care for patients with advanced non-small-cell lung carcinomas (NSCLC). A pilot clinical trial has reflected optimistic association between supplementation with Clostridium butyricum MIYAIRI 588 (CBM588) and ICI efficac...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Taylor & Francis Group
2024-12-01
|
| Серія: | Gut Microbes |
| Предмети: | |
| Онлайн доступ: | https://www.tandfonline.com/doi/10.1080/19490976.2024.2315631 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|